Journal Article Review Research Support, Non-U.S. Gov't Epublish 28 citations
PubMed: 36291105 DOI: 10.3390/cells11203237
Dual Immune Regulatory Roles of Interleukin-33 in Pathological Conditions.
Cells 11(20)
Authors: Han Guo, Elhusseny A Bossila, Xinran Ma, Chenxu Zhao, Yong Zhao
Affiliations
- State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China. University of Chinese Academy of Sciences, Beijing 101499, China.
- State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
- University of Chinese Academy of Sciences, Beijing 101499, China.
- Biotechnology Department, Faculty of Agriculture Al-Azhar University, Cairo 11311, Egypt.
- Beijing Institute for Stem Cell and Regeneration, Beijing 100101, China.
Abstract
Interleukin-33 (IL-33), a member of the IL-1 cytokine family and a multifunctional cytokine, plays critical roles in maintaining host homeostasis and in pathological conditions, such as allergy, infectious diseases, and cancer, by acting on multiple types of immune cells and promoting type 1 and 2 immune responses. IL-33 is rapidly released by immune and non-immune cells upon stimulation by stress, acting as an "alarmin" by binding to its receptor, suppression of tumorigenicity 2 (ST2), to trigger downstream signaling pathways and activate inflammatory and immune responses. It has been recognized that IL-33 displays dual-functioning immune regulatory effects in many diseases and has both pro- and anti-tumorigenic effects, likely depending on its primary target cells, IL-33/sST2 expression levels, cellular context, and the cytokine microenvironment. Herein, we summarize our current understanding of the biological functions of IL-33 and its roles in the pathogenesis of various conditions, including inflammatory and autoimmune diseases, infections, cancers, and cases of organ transplantation. We emphasize the nature of context-dependent dual immune regulatory functions of IL-33 in many cells and diseases and review systemic studies to understand the distinct roles of IL-33 in different cells, which is essential to the development of more effective diagnoses and therapeutic approaches for IL-33-related diseases.
MeSH
Cytokines, Cells, Neoplasms, Alarmins, Immune System, Immunity, Interleukin-33, Organ Transplantation
Cited by
- Eosinophils in the tumor microenvironment: implications for cancer immunotherapy. J Transl Med, 2023
- Are IL-1 family cytokines important in management of sickle cell disease in Sub-Saharan Africa patients? Front Immunol, 2023
- Oligodendrocyte-derived IL-33 regulates self-reactive CD8+ T cells in CNS autoimmunity. J Exp Med, 2025
- Transcriptomic and Functional Evidence That miRNA193a-3p Inhibits Lymphatic Endothelial Cell (LEC) and LEC + MCF-7 Spheroid Growth Directly and by Altering MCF-7 Secretome. Cells, 2023
- Integrative analysis reveals novel inflammatory and metabolic pathways in glioblastoma development: A large-scale mediation Mendelian randomization study. Medicine (Baltimore), 2025
- Biological mechanisms and therapeutic prospects of interleukin-33 in pathogenesis and treatment of allergic disease. J Inflamm (Lond), 2025
- Molecular Mechanisms Underlying IL-33-Mediated Inflammation in Inflammatory Bowel Disease. Int J Mol Sci, 2023
- Dynamics of inflammatory signals within the tumor microenvironment. World J Exp Med, 2025
- IL-33 Induces Cellular and Exosomal miR-146a Expression as a Feedback Inhibitor of Mast Cell Function. J Immunol, 2024
- Decoding the IL-33/ST2 Axis: Its Impact on the Immune Landscape of Breast Cancer. Int J Mol Sci, 2023
- Interleukin-33 and Obesity-Related Inflammation and Cancer. Encyclopedia (Basel, 2021), 2025